NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cell Microsystems

Cell Microsystems

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://cellmicrosystems.com/

Last Round

Series B

Aug 23, 2023

Total Funding Raised

$27.98M

Company Overview

Cell Microsystems is a biotechnology company that develops, manufactures, and markets products for single-cell biology, including its CellRaft AIR® System for cell engineering, culture, and analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

single cell analysissingle cell isolationcell line developmentgentle cell sortinglife science toolsCRISPR gene editingautomated cell sortingcolony pickerorganoid developmentlab consumablesimage-based cytometrybiotech equipmentCRO services3D cell cultureshear flow systemsAI image analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cell Microsystems Comparables

Compare Cell Microsystems with similar companies based on industry and business-model similarity.

Cell Microsystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoCellect Biomedical
81%
Deepcell
81%
Bruker
78%

Cell Microsystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 23, 2023
Series ANov 15, 2021
DebtSep 1, 2020
Convertible DebtFeb 21, 2019

Cell Microsystems Investors

Notable investors and investment history

Cell Microsystems investors
InvestorRounds
Telegraph Hill PartnersSeries B, Series A
North Carolina Biotechnology CenterDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors grew 200% MoM, reaching 8.4K.

  • Feb 20, 2025

    Monthly visitors grew 235% MoM, reaching 13.4K.

Cell Microsystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cell Microsystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cell Microsystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range21
Year Founded2010
Last FundingAug 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.